[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361373-105":59,"doc-detail-361373-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ctgfccn2-promotes-invasive-growth-in-cervical-cancer-spheroids-and-is-associated-with-metastatic-cervical-cancer-tissue-abstract","CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue - Abstract","","Metastatic spread drives the lethality of cervical cancer, yet the contribution of connective tissue growth factor (CTGF/CCN2) remains unclear. This study evaluated whether CTGF promotes invasive growth in cervical cancer spheroid models and determined its prevalence in patient tissues. Human CTGF or a CTGF-blocking antibody were applied, with invasion quantified in 3D assays, stemness and EMT markers mapped, and CTGF expression scored in tissue microarrays.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ctgfccn2-promotes-invasive-growth-in-cervical-cancer-spheroids-and-is-associated-with-metastatic-cervical-cancer-tissue-abstract/361373/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ctgfccn2-promotes-invasive-growth-in-cervical-cancer-spheroids-and-is-associated-with-metastatic-cervical-cancer-tissue-abstract/361373.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CTGF/CCN2 play in cervical cancer studied here?","Question",{"text":112,"@type":113},"The study investigates whether CTGF/CCN2 drives invasive growth in cervical cancer models and examines its abundance in patient tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cervical cancer spheroid invasion and marker changes assessed?",{"text":117,"@type":113},"Cervical cancer spheroids were treated with recombinant human CTGF or a CTGF-blocking antibody; invasion was quantified using a 3D spheroid assay, and stemness/EMT markers were examined by immunofluorescence.",{"name":119,"@type":110,"acceptedAnswer":120},"Is CTGF expression linked to patient prognosis and metastasis?",{"text":121,"@type":113},"Metastatic samples showed the highest CTGF fluorescence intensity, and high CTGF mRNA expression correlated with significantly reduced recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361373,1790728777,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","doi: 10.21873/cgp.20609  \nCTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and IsAssociated With Metastatic Cervical Cancer Tissue  \nLINDA VON DER BRELIE, NESIBEGÖKÇE KALYONCU, JULIA GALLWAS and CARSTEN GRÜNDKER Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany  \nAbstract  \nBackground/Aim: Metastatic spread defines the lethality of cervical cancer (CC) . Connective tissue growth factor (CTGF/CCN2) regulates cell- extracellular matrix interactions but its role in CC is not well-defined. This study investigates the role ofCTGF in driving CC invasive growth and its prevalence in patient tissues.  \nMaterials and Methods: CC spheroids (C33A, HT3) were treated with recombinant human CTGF (rhCTGF) or a functionblocking antibody (IgG CTGF). Invasive growth was assessed via 3D spheroid assay using a Celigo imaging cytometer. Cancer stem cell (CD133, CD44) and epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin) were analyzed by immunofluorescence. CTGF expression was evaluated using a tissue microarray containing 69 cases in triplicate from pre-invasive, invasive (FIGO I-III), and metastatic cervical lesions, quantified via immunofluorescence scoring.  \nResults: Functional blockade of CTGF significantly reduced 3D spheroid invasive growth inC33AandHT3 cells (p\u003C0.0001). Immunofluorescence revealed that CTGF modulation altered spatial distribution of key proteins: rhCTGF induced surface clustering of CD133 and peripheral N-cadherin enrichment, while CTGF blockade was associated with apparent nuclear/ perinuclear enrichment of CD133 and E-cadherin and reduced N-cadherin signal. In patient tissue cores, metastatic samples exhibited the highest CTGF fluorescence intensity. High CTGF expression [immunoreactivity score (IRS) ≥ 6] was most prevalent in FIGO stage I (35.5%) compared to stage III (10.0%). Kaplan-Meier analysis revealed that high CTGF mRNA expression was associated with significantly reduced recurrence-free survival (log-rank p=0.0032).  \nConclusion: In 3D models of CC, CTGF appears to regulate an invasive phenotype, presumably by controlling aberrant localization of stemness and EMT markers. Its apparently elevated expression in early-stage cervical carcinomas and metastases, combined with its prognostic value for recurrence-free survival, suggests that CTGF may be involved in triggering the potential for metastasis and could therefore serve as an early prognostic biomarker.  \nKeywords: Connective tissue growth factor, CTGF, CCN2, cervical cancer, CC, invasion, metastasis.  \n✉ Carsten Gründker, Department of Gynecology and Obstetrics, Robert-Koch-Str. 40, 37075 Göttingen, Germany. Tel: +49  \n551 3969810, [e-mail: grundker@med.uni-goettingen.de](e-mail: grundker@med.uni-goettingen.de)  \nReceived Μay 11, 2026 | Revised June 11, 2026 | Accepted June 24, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Published by the International Institute of Anticancer Research.  \nIntroduction  \nCervical cancer (CC), and in particular cervical squamous cell carcinoma (CSCC), remain a major global health burden (1-3) . Metastatic disease, often to pelvic lymph nodes and distant sites, is the primary cause of treatment failure and death (4). Up to 90% of cancer-related deaths are attributable to metastatic spread, and in cervical cancer, lymph node involvement significantly reduces 5-year overall survival from 95.6% to 77.7%(5) .  \nThe molecular mediators that enable CC cells to acquire invasive properties early in progression are incompletely characterized. Connective tissue growth factor (CTGF/CCN2) is a secreted matricellular protein central to wound healing and fibrosis, influencing cell adhesion, migration, and extracellular matrix production (6) . A primary function of CTGF is to ","cbCaisU4H2rOjw7x","https://ap.wps.com/l/cbCaisU4H2rOjw7x","pdf",4713630,14,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and Methods","[{\"question\":\"What role does CTGF/CCN2 play in cervical cancer studied here?\",\"answer\":\"The study investigates whether CTGF/CCN2 drives invasive growth in cervical cancer models and examines its abundance in patient tissues.\"},{\"question\":\"How were cervical cancer spheroid invasion and marker changes assessed?\",\"answer\":\"Cervical cancer spheroids were treated with recombinant human CTGF or a CTGF-blocking antibody; invasion was quantified using a 3D spheroid assay, and stemness/EMT markers were examined by immunofluorescence.\"},{\"question\":\"Is CTGF expression linked to patient prognosis and metastasis?\",\"answer\":\"Metastatic samples showed the highest CTGF fluorescence intensity, and high CTGF mRNA expression correlated with significantly reduced recurrence-free survival.\"}]","CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue - Abstract | PDF",1790144101,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e39846d29cbef86a782260b2cc2b211b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd11a49498583444cea2c1b8089d32cb.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67b571f80c38594b7bee4348de536e71.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8b352d3a4134d76244b035be18ceeb9.webp",980,1306]